First Cannabis Drug Wins FDA Approval Amidst $2.4 Billion Wave of Capital Investment, an Industrial Info Market Brief
First Cannabis Drug Wins FDA Approval Amidst $2.4 Billion Wave of Capital Investment, an Industrial Info Market Brief
British drugmaker GW Pharmaceuticals plc has won FDA approval for a pediatric epilepsy treatment, Epidiolex. What makes this noteworthy beyond the drug's promise in managing hard-to-treat seizures, is the fact that it is the first approved cannabis-based prescription drug. Cannabis, or marijuana, as it is more commonly known, remains illegal under federal law. That has not stopped the increasingly huge wave of approvals for both medicinal and recreational uses across the globe.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips